-+ 0.00%
-+ 0.00%
-+ 0.00%

*Biogen: Latest 2Q Includes Deal-Related Charges, Including Acquired IPR&D, Dilution Related to Apellis Acquisition and Continued Investment in Ongoing Phase 3 Development Programs >BIIB

Dow Jones·07/29/2026 10:01:00

登錄查看新聞詳情